Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The efficacy of low dose azathioprine/6-mercaptopurine in patients with inflammatory bowel disease.

Hepato-gastroenterology - 1 Jan 2000

Kim Dong Uk, Kim Young-Ho, Kim Beom Jin, Chang Dong Kyung, Son Hee Jung, Rhee Poong-Lyul, Kim Jae J, Rhee Jong Chul

Abstract excerpt

BACKGROUND/AIMS: Azathioprine (AZA) and 6-mercaptopurine (6-MP) have been widely used in patients with ulcerative colitis (UC) and Crohn's disease (CD). However, some patients cannot tolerate standard doses (2-2.5 mg/kg for AZA or 1-1.5 mg/kg for 6-MP) due to side effects such as leukopenialneutr...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Aged
Share to Azathioprine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Inflammatory Bowel Diseases

Share to Mercaptopurine

Share to Methyltransferases

Source

Identifiers

PMID: 19950798

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19950798-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

The efficacy of low dose azathioprine/6-mercaptopurine in patients with inflammatory bowel disease.PMID 19950798Read ↗

Low-dose azathioprine is effective and safe for maintenance of remission in patients with ulcerative colitis.Semantic proximity Read ↗

Use of 6-mercaptopurine/azathioprine as the immunomodulator of choice for moderately active Crohn's disease: balance.Semantic proximity Read ↗

Differences in the adverse effects of azathioprine between inflammatory bowel disease and autoimmune hepatitis in Korean patients.Semantic proximity Read ↗

Relationship between azathioprine dosage, 6-thioguanine nucleotide levels, and therapeutic response in pediatric patients with IBD treated with azathioprine.Semantic proximity Read ↗

Monitoring 6-thioguanine nucleotide concentrations in Japanese patients with inflammatory bowel disease.Semantic proximity Read ↗

A Prospective Study Evaluating Metabolic Capacity of Thiopurine and Associated Adverse Reactions in Japanese Patients with Inflammatory Bowel Disease (IBD).Semantic proximity Read ↗

6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.Semantic proximity Read ↗

Remission maintenance by tioguanine in chronic active Crohn's disease.Semantic proximity Read ↗

A prospective, open-label trial of 6-thioguanine in patients with ulcerative or indeterminate colitis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.